Literature DB >> 17143884

New mutation of the MPZ gene in a family with the Dejerine-Sottas disease phenotype.

Paraskewi Floroskufi1, Marios Panas, Georgia Karadima, Demetris Vassilopoulos.   

Abstract

Charcot-Marie-Tooth disease type 1B is associated with mutations in the myelin protein zero gene. In the present study a new myelin protein zero gene mutation (c.89T>C,Ile30Thr) was detected in a family with the Dejerine-Sottas disease phenotype. The results support the hypothesis that severe, early-onset neuropathy may be related to either an alteration of a conserved amino acid or a disruption of the tertiary structure of myelin protein zero.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143884     DOI: 10.1002/mus.20703

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Cellular characterization of MPZ mutations presenting with diverse clinical phenotypes.

Authors:  Yi-Chung Lee; Kon-Ping Lin; Ming-Hong Chang; Yi-Chu Liao; Ching-Piao Tsai; Kwong-Kum Liao; Bing-Wen Soong
Journal:  J Neurol       Date:  2010-05-12       Impact factor: 4.849

2.  Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype.

Authors:  Ilaria Callegari; C Gemelli; A Geroldi; F Veneri; P Mandich; M D'Antonio; D Pareyson; M E Shy; A Schenone; V Prada; M Grandis
Journal:  J Neurol       Date:  2019-07-05       Impact factor: 4.849

3.  Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations.

Authors:  Gabriel Miltenberger-Miltenyi; Thomas Schwarzbraun; Wolfgang N Löscher; Julia Wanschitz; Christian Windpassinger; Hans-Christoph Duba; Rainer Seidl; Gerhard Albrecht; Helga Weirich-Schwaiger; Heinz Zoller; Gerd Utermann; Michaela Auer-Grumbach; Andreas R Janecke
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

Review 4.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.